142 withdrawn. 142 Phase 1, 63 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 142 | Withdrawn 142 |
| Phase 2 | 63 | Withdrawn 63 |
Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma Allogeneic Hematopoietic Stem Cell Transplantation, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Cyclophosphamide - Multiple Myeloma, Recurrent Multiple Myeloma | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2027-06-01 | 2026-09-11 | |
| Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients Metformin, Val, Cel and Met XR Low, Val, Cel and Met XR High - Type 2 Diabetes, High Blood Pressure | Phase 1 / Phase 2 | Withdrawn | ARKAY Therapeutics | 2026-12-10 | 2026-07-16 | |
| Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema Octreotide (drug), Placebo - Diabetic Macular Edema | Phase 1 | Withdrawn | University of Alabama at Birmingham | 2026-08-31 | 2026-10-13 | |
| A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia Oxygen, Room air - Pulmonary Hypertension | Phase 1 / Phase 2 | Withdrawn | Duke University | 2026-07-01 | 2026-09-03 | |
| Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2026-04-01 | 2026-05-15 | |
| A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia TER-1754, Placebo - Hereditary Hemorrhagic Telangiectasia (HHT) | Phase 1 | Withdrawn | Terremoto Biosciences Inc. | 2025-12-15 | 2026-04-13 | |
| UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma UF-KURE-BCMA CAR T-cells, Cyclophosphamide, Fludarabine - Multiple Myeloma, Multiple Myeloma in Relapse | Phase 1 | Withdrawn | David Wald | 2025-09-01 | 2026-05-13 | |
| The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. Autologous hMSCs, Autologous Human C-Kit CSCs II, Placebo - Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction | Phase 1 / Phase 2 | Withdrawn | Joshua M Hare | 2025-03-01 | 2020-10-22 | |
| Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells Commercial CAR-T, Investigational CAR-T - Malignancy, Cancer | Phase 1 / Phase 2 | Withdrawn | UNC Lineberger Comprehensive Cancer Center | 2025-01-20 | 2026-01-06 | |
| A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors 225Ac-DOTATATE - Multiple Myeloma, Refractory, Multiple Myeloma in Relapse | Phase 1 | Withdrawn | Jules Bordet Institute | 2024-10-01 | 2025-01-31 | |
| PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia Caffeine citrate - Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy | Phase 1 | Withdrawn | University of Arkansas | 2024-05-08 | 2024-05-10 | |
| CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Withdrawn | Jonsson Comprehensive Cancer Center | 2024-03-28 | 2024-05-01 | |
| Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Melphalan, Peripheral Blood Stem Cell Transplantation - Plasma Cell Myeloma | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2024-01-27 | 2024-01-31 | |
| PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke Hypoxia, intermittent, Normoxia - Stroke, Ischemic, Stroke Sequelae | Phase 1 / Phase 2 | Withdrawn | University Hospital, Grenoble | 2024-01-01 | 2024-06-04 | |
| Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache Botox 200 UNT Injection, Non Botox based Standard of Care Treatments for Headache/Migraine - Stroke (CVA) or TIA, Headache, Migraine | Phase 1 | Withdrawn | University of Alberta | 2023-12-01 | 2024-09-19 | |
| An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma ICI201 - Relapsed/Refractory Multiple Myeloma | Phase 1 | Withdrawn | The First Affiliated Hospital of Soochow University | 2023-10-09 | 2023-12-22 | |
| Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma Mezigdomide, Ixazomib, Dexamethasone - Relapsed and Refractory Multiple Myeloma | Phase 1 / Phase 2 | Withdrawn | Kathleen Dorritie | 2023-10-02 | 2024-11-19 | |
| Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Sonodynamic therapy (SDT), pseudo-SDT - Carotid Atherosclerosis | Phase 1 / Phase 2 | Withdrawn | First Affiliated Hospital of Harbin Medical University | 2023-09-20 | 2023-09-21 | |
| A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) AMG 701 - Relapsed/Refractory Multiple Myeloma | Phase 1 | Withdrawn | Amgen | 2023-08-29 | 2022-09-27 | |
| mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM) mRNA-2736 - Relapsed or Refractory Multiple Myeloma | Phase 1 | Withdrawn | ModernaTX, Inc. | 2023-08-15 | 2023-08-18 |
Showing 20 of 142. Sign in to see all of them.
Multiple Myeloma (44) · Stroke (20) · Ischemic Stroke (12) · Hypertension (9) · Lymphoma, B-Cell, Marginal Zone (8) · Lymphoma, Mantle-Cell (8) · Hypertension, Pulmonary (7) · Leukemia, Lymphocytic, Chronic, B-Cell (7) · Lymphoma, Follicular (7) · Lymphoma, Non-Hodgkin (7) · Recurrence (7) · Waldenstrom Macroglobulinemia (7) · Coronary Artery Disease (6) · Lymphoma (6) · Lymphoma, Large B-Cell, Diffuse (6)
Cardiovascular Diseases (139) · Hemic and Lymphatic Diseases (54) · Hematologic Diseases (53) · Hemorrhagic Disorders (53) · Hemostatic Disorders (52) · Immune System Diseases (52) · Blood Protein Disorders (50) · Immunoproliferative Disorders (50) · Neoplasms (50) · Neoplasms by Histologic Type (50) · Paraproteinemias (50) · Lymphoproliferative Disorders (49) · Neoplasms, Plasma Cell (47) · Pathological Conditions, Signs and Symptoms (47)
Dexamethasone (15) · Calcium Dobesilate (9) · Bortezomib (8) · Lenalidomide (8) · Sodium Chloride (7) · Cyclophosphamide (6) · Melphalan (6) · Leukapheresis (3) · Magnetic Resonance Spectroscopy (3) · Saline Solution (3) · Tissue Plasminogen Activator (3) · auricularum (3) · daratumumab (3) · dexamethasone 21-phosphate (3) · dexamethasone acetate (3)
University of California, San Diego (6) · Mayo Clinic (4) · First Affiliated Hospital of Harbin Medical University (3) · University of Arkansas (3) · Yale University (3) · Ageless Regenerative Institute (2) · Dana-Farber Cancer Institute (2) · Fred Hutchinson Cancer Center (2) · Jonsson Comprehensive Cancer Center (2) · Karyopharm Therapeutics Inc (2) · M.D. Anderson Cancer Center (2) · Massachusetts General Hospital (2) · National Cancer Institute (NCI) (2) · Neurogen Brain and Spine Institute (2) · University Medicine Greifswald (2)
United States (70) · Canada (8) · China (5) · Israel (4) · Australia (3) · Belgium (3) · Germany (3) · Taiwan (3) · United Kingdom (3) · France (2) · Greece (2) · India (2) · Italy (2) · South Korea (2) · Spain (2)
Matt B Jensen, MD (4) · Lars R Herda, MD (2) · Alan H Maurer, MD (1) · Alison Morris, MD, MS (1) · Alok K Sharma, M.S., M.Ch (1) · Amr Abbas, M.D. (1) · Andrew Baker, MD (1) · Andrew J. Yee, MD (1) · Arya Mani, MD (1) · Astrid Hummel, MD (1) · Barry Oken, MD (1) · Beverly C Walters, MD (1) · Binod Dhakal, MD (1)
PMID 25126443, PMID 25164919, PMID 25500317, PMID 26381856, PMID 27910097, PMID 29765218, PMID 30152015, PMID 30232673, PMID 30617735, PMID 33175411
2015 (1), 2016 (1), 2023 (1), K23DK064587 (1), K23HL098454 (1), P01CA078902 (1), P01HL103455 (1), P30CA015083 (1), P30CA022453 (1), P50NS044148 (1), R01CA205248 (1), R01HL132448 (1), U10CA180820 (1), UM1CA186644 (1)